Prospective comparison of 68Ga-DOTATATE and 18F-FDOPA PET/CT in patients with various pheochromocytomas and paragangliomas with emphasis on sporadic cases
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prospective comparison of 68Ga-DOTATATE and 18F-FDOPA PET/CT in patients with various pheochromocytomas and paragangliomas with emphasis on sporadic cases
Authors
Keywords
Positron emission tomography, Gallium radioisotopes, Somatostatin, Paragangliomas, Neuroendocrine
Journal
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Volume 43, Issue 7, Pages 1248-1257
Publisher
Springer Nature
Online
2015-12-05
DOI
10.1007/s00259-015-3268-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Moving Beyond "Lumpology": PET/CT Imaging of Pheochromocytoma and Paraganglioma
- (2015) M. S. Hofman et al. CLINICAL CANCER RESEARCH
- Superiority of [68Ga]-DOTATATE PET/CT to Other Functional Imaging Modalities in the Localization of SDHB-Associated Metastatic Pheochromocytoma and Paraganglioma
- (2015) I. Janssen et al. CLINICAL CANCER RESEARCH
- Comparison of 18F-FDG and 68Ga DOTATATE PET/CT in Localization of Tumor Causing Oncogenic Osteomalacia
- (2015) Kanhaiyalal Agrawal et al. CLINICAL NUCLEAR MEDICINE
- Accuracy of 68Ga DOTANOC PET/CT Imaging in Patients With Multiple Endocrine Neoplasia Syndromes
- (2015) Punit Sharma et al. CLINICAL NUCLEAR MEDICINE
- 15 YEARS OF PARAGANGLIOMA: Imaging and imaging-based treatment of pheochromocytoma and paraganglioma
- (2015) Frédéric Castinetti et al. ENDOCRINE-RELATED CANCER
- Magnetic resonance spectroscopy of paragangliomas: new insights intoin vivometabolomics
- (2015) Arthur Varoquaux et al. ENDOCRINE-RELATED CANCER
- Somatostatin Receptor Imaging with68Ga DOTATATE PET/CT: Clinical Utility, Normal Patterns, Pearls, and Pitfalls in Interpretation
- (2015) Michael S. Hofman et al. RADIOGRAPHICS
- 68Ga DOTA-TATE PET/CT allows tumor localization in patients with tumor-induced osteomalacia but negative 111In-octreotide SPECT/CT
- (2014) Stefan Breer et al. BONE
- Current Approaches and Recent Developments in the Management of Head and Neck Paragangliomas
- (2014) David Taïeb et al. ENDOCRINE REVIEWS
- 68Ga-DOTATOC PET/CT provides accurate tumour extent in patients with extraadrenal paraganglioma compared to 123I-MIBG SPECT/CT
- (2014) Alexander Kroiss et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- SDH Mutations Establish a Hypermethylator Phenotype in Paraganglioma
- (2013) Eric Letouzé et al. CANCER CELL
- Integrated Whole-Body PET/MRI With 18F-FDG, 18F-FDOPA, and 18F-FDA in Paragangliomas in Comparison With PET/CT
- (2013) Elise M. Blanchet et al. CLINICAL NUCLEAR MEDICINE
- A retrospective comparison between 68Ga-DOTA-TOC PET/CT and 18F-DOPA PET/CT in patients with extra-adrenal paraganglioma
- (2013) Alexander Kroiss et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- 68Ga-DOTA-TOC uptake in neuroendocrine tumour and healthy tissue: differentiation of physiological uptake and pathological processes in PET/CT
- (2013) A. Kroiss et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- 68Ga-DOTANOC PET/CT for Baseline Evaluation of Patients with Head and Neck Paraganglioma
- (2013) P. Sharma et al. JOURNAL OF NUCLEAR MEDICINE
- Functional characterization of nonmetastatic paraganglioma and pheochromocytoma by18F-FDOPA PET: focus on missed lesions
- (2012) Sophie Gabriel et al. CLINICAL ENDOCRINOLOGY
- 68Ga-labelled peptides in the management of neuroectodermal tumours
- (2012) Meeran Naji et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Expression of somatostatin receptors, dopamine D2 receptors, noradrenaline transporters, and vesicular monoamine transporters in 52 pheochromocytomas and paragangliomas
- (2011) A. Saveanu et al. ENDOCRINE-RELATED CANCER
- Functional Imaging ofSDHx-Related Head and Neck Paragangliomas: Comparison of18F-Fluorodihydroxyphenylalanine,18F-Fluorodopamine,18F-Fluoro-2-Deoxy-d-Glucose PET,123I-Metaiodobenzylguanidine Scintigraphy, and111In-Pentetreotide Scintigraphy
- (2011) Kathryn S. King et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Comparison of [111In]pentetreotide-SPECT and [18F]FDOPA-PET in the localization of extra-adrenal paragangliomas: the case for a patient-tailored use of nuclear imaging modalities
- (2010) N. Charrier et al. CLINICAL ENDOCRINOLOGY
- 6-18F-Fluoro-l-Dihydroxyphenylalanine Positron Emission Tomography Is Superior to123I-Metaiodobenzyl-Guanidine Scintigraphy in the Detection of Extraadrenal and Hereditary Pheochromocytomas and Paragangliomas: Correlation with Vesicular Monoamine Transporter Expression
- (2010) C. Fottner et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- 68Ga-DOTA-TATE PET vs. 123I-MIBG in Identifying Malignant Neural Crest Tumours
- (2010) Meeran Naji et al. MOLECULAR IMAGING AND BIOLOGY
- 6-[F-18]Fluoro-l-Dihydroxyphenylalanine Positron Emission Tomography Is Superior to Conventional Imaging with123I-Metaiodobenzylguanidine Scintigraphy, Computer Tomography, and Magnetic Resonance Imaging in Localizing Tumors Causing Catecholamine Excess
- (2009) Helle-Brit Fiebrich et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Head and Neck Paragangliomas: Value of Contrast-Enhanced 3D MR Angiography
- (2008) F. Neves et al. AMERICAN JOURNAL OF NEURORADIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search